Hood River Capital Management LLC lifted its stake in shares of Teladoc, Inc. (NYSE:TDOC) by 38.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 963,839 shares of the health services provider’s stock after purchasing an additional 265,855 shares during the period. Teladoc makes up about 2.0% of Hood River Capital Management LLC’s holdings, making the stock its 9th biggest position. Hood River Capital Management LLC owned 1.69% of Teladoc worth $31,951,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the company. Rosenblum Silverman Sutton S F Inc. CA raised its position in shares of Teladoc by 2.7% during the second quarter. Rosenblum Silverman Sutton S F Inc. CA now owns 67,395 shares of the health services provider’s stock worth $2,339,000 after purchasing an additional 1,800 shares during the period. Bank of Montreal Can raised its position in shares of Teladoc by 214.2% during the second quarter. Bank of Montreal Can now owns 3,516 shares of the health services provider’s stock worth $123,000 after purchasing an additional 2,397 shares during the period. Legal & General Group Plc raised its position in shares of Teladoc by 66.3% during the first quarter. Legal & General Group Plc now owns 6,137 shares of the health services provider’s stock worth $154,000 after purchasing an additional 2,446 shares during the period. Raymond James Trust N.A. raised its position in shares of Teladoc by 36.2% during the third quarter. Raymond James Trust N.A. now owns 9,943 shares of the health services provider’s stock worth $330,000 after purchasing an additional 2,643 shares during the period. Finally, American International Group Inc. raised its position in shares of Teladoc by 22.2% during the first quarter. American International Group Inc. now owns 14,575 shares of the health services provider’s stock worth $364,000 after purchasing an additional 2,644 shares during the period.

COPYRIGHT VIOLATION NOTICE: This report was originally published by Watch List News and is the sole property of of Watch List News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.watchlistnews.com/hood-river-capital-management-llc-increases-stake-in-teladoc-inc-tdoc/1707502.html.

Shares of Teladoc, Inc. (NYSE TDOC) traded down $0.25 during midday trading on Thursday, reaching $28.05. The company’s stock had a trading volume of 1,254,300 shares, compared to its average volume of 921,378. The company has a current ratio of 5.08, a quick ratio of 5.08 and a debt-to-equity ratio of 0.83. Teladoc, Inc. has a 1 year low of $15.65 and a 1 year high of $37.55.

Teladoc (NYSE:TDOC) last issued its earnings results on Wednesday, November 1st. The health services provider reported ($0.55) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.25). Teladoc had a negative net margin of 39.61% and a negative return on equity of 21.59%. The firm had revenue of $68.70 million during the quarter, compared to analysts’ expectations of $67.53 million. During the same quarter last year, the firm earned ($0.33) EPS. The business’s revenue for the quarter was up 112.0% compared to the same quarter last year. equities research analysts anticipate that Teladoc, Inc. will post -1.57 EPS for the current fiscal year.

Several research analysts recently weighed in on TDOC shares. BidaskClub raised Teladoc from a “sell” rating to a “hold” rating in a research report on Wednesday, September 6th. Piper Jaffray Companies reissued a “buy” rating and set a $42.00 price target on shares of Teladoc in a research report on Friday, July 28th. KeyCorp reissued a “buy” rating and set a $37.00 price target on shares of Teladoc in a research report on Sunday, September 17th. Cantor Fitzgerald reissued a “hold” rating and set a $31.00 price target on shares of Teladoc in a research report on Tuesday, September 26th. Finally, Zacks Investment Research raised Teladoc from a “sell” rating to a “hold” rating in a research report on Thursday, September 21st. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and nine have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $38.17.

In other Teladoc news, VP Mark Hirschhorn sold 25,000 shares of the business’s stock in a transaction dated Friday, September 22nd. The stock was sold at an average price of $31.93, for a total value of $798,250.00. Following the transaction, the vice president now owns 64,987 shares in the company, valued at $2,075,034.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Jason N. Gorevic sold 20,000 shares of the business’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $33.47, for a total value of $669,400.00. The disclosure for this sale can be found here. Insiders sold 135,000 shares of company stock worth $4,408,700 in the last 90 days. Corporate insiders own 4.47% of the company’s stock.

About Teladoc

Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

Institutional Ownership by Quarter for Teladoc (NYSE:TDOC)

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.